Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritis
Hy2Care has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Hy2Care's investors include European Innovation Council, Startupbootcamp, Brightlands Venture Partners, LIOF, ReumaNederland.
Hy2Care is headquartered in Enschede, The Netherlands.
Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritis
Hy2Care is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hy2Care — Funding & Investors." VCBacked, May 14, 2025, https://www.vcbacked.co/company/hy2care. Accessed July 19, 2026.
VCBacked. (2025). Hy2Care — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/hy2care
{{cite web |title=Hy2Care — Funding & Investors |url=https://www.vcbacked.co/company/hy2care |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated